Rani Therapeutics Holdings, Inc. Contracts & Agreements
57 Contracts & Agreements
- Business Finance (22 contracts)
- Business Formation (1)
- Business Operations (9)
- Human Resources (12)
- Intellectual Property (4)
- Real Estate (1)
- Uncategorized (8)
- Amendment to Securities Purchase Agreement and Series B Common Stock Purchase Warrant dated September 23, 2024 between Rani Therapeutics Holdings, Inc. and the investors specified... (Filed With SEC on November 14, 2024)
- Form of Series C Common Warrant (Filed With SEC on October 16, 2024)
- Form of Pre-funded Warrant (Filed With SEC on October 16, 2024)
- Form of Securities Purchase Agreement, dated October 15, 2024 (Filed With SEC on October 16, 2024)
- Collaboration Agreement between Rani Therapeutics, LLC and ProGen Co., Ltd. dated June 17, 2024 (Filed With SEC on August 6, 2024)
- Extension of Intellectual Property Agreement dated June 12, 2024 by and between Rani Therapeutics, LLC and Mir Imran (Filed With SEC on August 6, 2024)
- Form of Series A Common Warrant (Filed With SEC on July 23, 2024)
- Form of Series B Common Warrant (Filed With SEC on July 23, 2024)
- Form of Pre-funded Warrant (Filed With SEC on July 23, 2024)
- Form of Securities Purchase Agreement, dated July 22, 2024 (Filed With SEC on July 23, 2024)
- Amendment No. 2 to Service Agreement, dated March 15, 2024, by and between Rani Therapeutics, LLC and InCube Labs, LLC (Filed With SEC on March 20, 2024)
- Amendment No. 1 to RMS Service Agreement, dated March 15, 2024, by and between Rani Therapeutics, LLC and InCube Labs, LLC (Filed With SEC on March 20, 2024)
- Standard Industrial/Commercial Multi-Tenant Lease Net, by and between Rani Therapeutics, LLC and BKM South Bay 240, LLC, dated as of November 1, 2023 (Filed With SEC on November 8, 2023)
- License and Supply Agreement by and between Rani Therapeutics, LLC and Celltrion, Inc. dated May 26, 2023 (Filed With SEC on August 11, 2023)
- Employment Agreement, dated May 17, 2023, by and between Rani Therapeutics, LLC and Kate McKinley (Filed With SEC on August 11, 2023)
- Controlled EquitySM Sales Agreement, dated August 24, 2022, by and among Rani Therapeutics Holdings, Inc., and Cantor Fitzgerald & Co. and H.C. Wainwright & Co., LLC (Filed With SEC on August 25, 2022)
- Description of Securities (Filed With SEC on August 10, 2022)
- Loan and Security Agreement, dated August 8, 2022, by and among the Registrant, its subsidiaries Rani Therapeutics, LLC and Rani Management Services, Inc., and Avenue Venture... (Filed With SEC on August 10, 2022)
- Supplement to the Loan and Security Agreement, dated August 8, 2022, by and among the Registrant, its subsidiaries Rani Therapeutics, LLC and Rani Management Services, Inc., and... (Filed With SEC on August 10, 2022)
- Form of Warrant to purchase shares of Class A common stock of Registrant, issued to Avenue Venture Opportunities Fund, L.P (Filed With SEC on August 10, 2022)
- Employment Agreement, dated April 12, 2022, by and between Rani Therapeutics, LLC and Eric Groen (Filed With SEC on May 11, 2022)
- Description of Securities (Filed With SEC on March 31, 2022)
- Tax Receivable Agreement, effective as of August 3, 2021 (Filed With SEC on March 31, 2022)
- Class B Unit Exchange Agreement, effective as of August 3, 2021 (Filed With SEC on March 31, 2022)
- Registration Rights Agreement, effective as of August 3, 2021 (Filed With SEC on March 31, 2022)
- Form of Underwriting Agreement (Filed With SEC on July 26, 2021)
- Specimen Class A common stock certificate of Rani Therapeutics Holdings, Inc (Filed With SEC on July 26, 2021)
- Rani Therapeutics Holdings, Inc. 2021 Equity Incentive Plan and forms of agreement thereunder (Filed With SEC on July 26, 2021)
- Rani Therapeutics Holdings, Inc. 2021 Employee Stock Purchase Plan (Filed With SEC on July 26, 2021)
- Amended and Restated Employment Agreement, dated June 17, 2021, by and between Rani Management Services, Inc. and Mir Hashim (Filed With SEC on July 26, 2021)
- Form of Tax Receivable Agreement, to be effective upon the closing of this offering (Filed With SEC on July 16, 2021)
- Form of Class B Unit Exchange Agreement, to be effective upon the closing of this offering (Filed With SEC on July 16, 2021)
- Form of Registration Rights Agreement, to be effective upon the closing of this offering (Filed With SEC on July 16, 2021)
- Form of Fifth Amended and Restated Limited Liability Company Agreement of Rani Therapeutics, LLC, to be effective upon the effectiveness of this offering (Filed With SEC on July 16, 2021)
- Rani Therapeutics Holdings, Inc. Non-Employee Director Compensation Policy (Filed With SEC on July 16, 2021)
- Form of Indemnification Agreement between Rani Therapeutics Holdings, Inc. and each of its directors and executive officers (Filed With SEC on July 9, 2021)
- Rani Therapeutics, LLC 2016 Equity Incentive Plan and forms of agreement thereunder (Filed With SEC on July 9, 2021)
- Rani Therapeutics Holdings, Inc. 2021 Equity Incentive Plan and forms of agreement thereunder (Filed With SEC on July 9, 2021)
- Rani Therapeutics Holdings, Inc. 2021 Employee Stock Purchase Plan (Filed With SEC on July 9, 2021)
- Rani Therapeutics Holdings, Inc. Severance and Change in Control Plan (Filed With SEC on July 9, 2021)
- Form of Participation Agreement under the Rani Therapeutics Holdings, Inc. Severance and Change in Control Plan (Filed With SEC on July 9, 2021)
- Exclusive License Agreement, by and between Rani Therapeutics, LLC and InCube Labs, LLC, dated June 14, 2012 (Filed With SEC on July 9, 2021)
- Intellectual Property Agreement, by and between Rani Therapeutics, LLC and InCube Labs, LLC, dated June 14, 2012 (Filed With SEC on July 9, 2021)
- Acknowledgement and Amendment, by and between Rani Therapeutics, LLC and InCube Labs, LLC, dated June 13, 2013 (Filed With SEC on July 9, 2021)
- Service Agreement, by and between Rani Therapeutics, LLC and InCube Labs, LLC, dated January 1, 2019 (Filed With SEC on July 9, 2021)
- Amendment No. 1 to Service Agreement, by and between Rani Therapeutics, LLC and InCube Labs, LLC, dated January 1, 2020 (Filed With SEC on July 9, 2021)
- Service Agreement, by and between Rani Therapeutics, LLC and InCube Labs, LLC, dated January 1, 2021 (Filed With SEC on July 9, 2021)
- Service Agreement, by and between Rani Management Services, Inc. and InCube Labs, LLC, dated January 1, 2021 (Filed With SEC on July 9, 2021)
- Amended and Restated Exclusive License Agreement, by and between Rani Therapeutics, LLC and InCube Labs, LLC, dated June 22, 2021 (Filed With SEC on July 9, 2021)
- Non-Exclusive License Agreement, by and between Rani Therapeutics, LLC and InCube Labs, LLC, dated June 22, 2021 (Filed With SEC on July 9, 2021)
- Intellectual Property Agreement, by and between Rani Therapeutics, LLC and Mir A. Imran, dated June 22, 2021 (Filed With SEC on July 9, 2021)
- Loan and Security Agreement, by and between Rani Therapeutics, LLC and Avenue Venture Opportunities Fund, L.P., dated September 15, 2020 (Filed With SEC on July 9, 2021)
- Promissory Note, by and between Rani Therapeutics, LLC and Avenue Venture Opportunities Fund, L.P., dated September 15, 2020 (Filed With SEC on July 9, 2021)
- Supplement to the Loan and Security Agreement, by and between Rani Therapeutics, LLC and Avenue Venture Opportunities Fund, L.P., dated September 15, 2020 (Filed With SEC on July 9, 2021)
- Amended and Restated Employment Agreement, dated June 17, 2021, by and between Rani Management Services, Inc. and Talat Imran (Filed With SEC on July 9, 2021)
- Amended and Restated Employment Agreement, dated June 17, 2021, by and between Rani Management Services, Inc. and Mir Hashim (Filed With SEC on July 9, 2021)
- Amended and Restated Employment Agreement, dated June 17, 2021, by and between Rani Management Services, Inc. and Svai Sanford (Filed With SEC on July 9, 2021)
